Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC22A14 Inhibitors

SLC22A14 inhibitors are a class of chemical compounds designed to selectively block the activity of the solute carrier family 22 member 14 (SLC22A14) protein, a transporter that is part of the broader SLC22 family. This family is known for its role in transporting a variety of organic cations, anions, and other small molecules across cellular membranes. SLC22A14, although not as well-characterized as other members of the family, is believed to be involved in the transport of organic compounds, possibly including metabolites, amino acids, or other biologically significant molecules. Inhibitors of SLC22A14 are designed to bind to specific regions of the transporter, preventing the movement of its substrates across cell membranes. By doing so, these inhibitors affect cellular processes dependent on the proper regulation of molecular transport, thereby altering the intracellular and extracellular balance of important metabolites.

The development of SLC22A14 inhibitors involves a comprehensive understanding of the transporter's structural and functional properties. Using advanced techniques such as molecular docking, X-ray crystallography, and computational modeling, researchers identify the key active sites of SLC22A14 that are critical for its transport activity. Once these regions are mapped, chemical compounds are designed to interact with these sites, inhibiting the transporter's function without impacting other similar proteins in the SLC family. These inhibitors are tested through various in vitro assays, including transport assays and binding affinity studies, to assess their efficacy and selectivity. The study of SLC22A14 inhibitors provides valuable insights into the biological roles of this transporter and contributes to a broader understanding of how solute carrier proteins regulate critical cellular processes such as nutrient uptake, waste removal, and the maintenance of cellular homeostasis. By inhibiting SLC22A14, researchers can better explore its functional significance in cellular metabolism and its interactions within the broader network of transporters.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$27.00
$38.00
$98.00
$272.00
28
(2)

Inhibits various anion transporters and may indirectly affect SLC22A14-related transport processes.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

A known inhibitor of certain cation transporters, potentially influencing SLC22A14 activity indirectly.

Verapamil

52-53-9sc-507373
1 g
$367.00
(0)

Blocks calcium channels but may also affect the function of some solute carriers by altering cellular ion balance.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Antagonist of the angiotensin II receptor but also reported to inhibit organic anion transporters.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$28.00
$37.00
18
(1)

Nonselective inhibitor of cyclooxygenase, but affects organic anion transporters indirectly.

Quinidine

56-54-2sc-212614
10 g
$102.00
3
(1)

Known to inhibit multiple cation transporters and could indirectly impact SLC22A14's function.

Omeprazole

73590-58-6sc-202265
50 mg
$66.00
4
(1)

Primarily a proton pump inhibitor but has been shown to affect the function of certain transporters indirectly.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$43.00
$65.00
$200.00
$815.00
6
(1)

Could influence NAD+ metabolism and indirectly affect transporters related to SLC22A14.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Primarily targets AMPK but also affects cellular transport processes, potentially impacting SLC22A14.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$252.00
$495.00
9
(1)

While its primary action is as an HMG-CoA reductase inhibitor, it can indirectly affect transporter activity.